Olivia Ware
Direktor/Vorstandsmitglied bei REVANCE THERAPEUTICS, INC.
Vermögen: 104 211 $ am 30.04.2024
Aktive Positionen von Olivia Ware
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
REVANCE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 06.03.2021 | - |
Independent Dir/Board Member | 06.03.2021 | - | |
ARCELLX, INC. | Direktor/Vorstandsmitglied | 16.05.2022 | - |
Independent Dir/Board Member | 16.05.2022 | - | |
CONTINEUM THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.03.2024 | - |
Karriereverlauf von Olivia Ware
Ehemalige bekannte Positionen von Olivia Ware
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Direktor/Vorstandsmitglied | 01.04.2021 | 01.06.2022 |
Independent Dir/Board Member | 01.04.2021 | 01.06.2022 | |
PRINCIPIA BIOPHARMA INC. | Corporate Officer/Principal | 01.11.2019 | 01.03.2021 |
Proteus Digital Health, Inc.
Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Proteus Digital Health, Inc. develops medicine products and therapeutic devices. It provides digital health products that collect behavioral, physiologic, and therapeutic metrics, such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels into personal management tools delivered to the mobile devices of consumers. The company was founded by Andrew M. Thompson, George M. Savage, and Mark J. Zdeblick in 2001 and is headquartered in Redwood City, CA. | Corporate Officer/Principal | 01.01.2018 | 01.01.2019 |
LADRX CORPORATION | Corporate Officer/Principal | 11.01.2016 | 01.01.2017 |
AMBRX INC | Direktor/Vorstandsmitglied | 14.04.2021 | - |
Ausbildung von Olivia Ware
Davidson College | Undergraduate Degree |
The University of North Carolina at Chapel Hill | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 10 |
Cayman Islands | 2 |
Operativ
Director/Board Member | 5 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 3 |
Sektoral
Health Technology | 9 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
LADRX CORPORATION | Health Technology |
REVANCE THERAPEUTICS, INC. | Health Technology |
ARCELLX, INC. | Health Technology |
CONTINEUM THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Principia Biopharma, Inc.
Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Principia Biopharma, Inc. is a biopharmaceutical company, which engages in designing and developing oral therapies to patients with significant unmet medical needs in immunology and oncology. It operates through Tailored Covalency platform, which enables to develop small molecule inhibitors of enzymes and receptor ligands with potencies and selectivities that rival those of injectable biologics, yet maintain the convenience of a pill. Its product pipeline includes PRN1008, PRN2246, PRN1371, and immunoproteasome inhibitor. The company was founded by Jack Taunton and Richard A. Miller on October 6, 2008 and is headquartered in South San Francisco, CA. | Health Technology |
Proteus Digital Health, Inc.
Proteus Digital Health, Inc. Pharmaceuticals: MajorHealth Technology Proteus Digital Health, Inc. develops medicine products and therapeutic devices. It provides digital health products that collect behavioral, physiologic, and therapeutic metrics, such as medication adherence, heart rate, sleep patterns, physical activity, and stress levels into personal management tools delivered to the mobile devices of consumers. The company was founded by Andrew M. Thompson, George M. Savage, and Mark J. Zdeblick in 2001 and is headquartered in Redwood City, CA. | Health Technology |
Ambrx, Inc.
Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Health Technology |
- Börse
- Insiders
- Olivia Ware
- Erfahrung